跳至主要内容
临床试验/CTRI/2020/01/022780
CTRI/2020/01/022780招募中4 期

Study on Comparison of Safety and Efficacy of Glycopyrrolate/Formoterol versus Tiotropium/Formoterol in Patients with COPD.

SRM COLLEGE OF PHARMACY SRMIST0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Ex-smokers
  • 2.Clinical history of moderate to severe COPD, (Global Initiative for Chronic Obstructive Lung Disease [GOLD] Stage II or III according to 2019 GOLD guidelines)
  • 3.Post bronchodilator forced expiratory volume in 1 second (FEV1 ) >= 30% and <80% of predicted
  • 4.Post bronchodilator FEV1/forced vital capacity (FVC) <0.70 at screening

排除标准

  • 1.Pregnant and lactating women
  • 2.Known history of psychiatric illness
  • 3.Moderate or severe renal impairment
  • 4.Patients with urinary retention
  • 5.Narrow-angle glaucoma
  • 6.Known history of alpha-1 antitrypsin deficiency
  • 7.Other underlying respiratory diseases other than COPD
  • 8.Surgeries including lobectomy or bronchoscopic lung volume reduction
  • 9.Inability to produce acceptable/reproducible spirometry results
  • 10.Contraindications to Glycopyrrolate, Formoterol or Tiotropium
  • 11.History of adverse reactions to inhaled anticholinergics
  • 12.Patients with known malignancies

研究者

发起方
SRM COLLEGE OF PHARMACY SRMIST

相似试验